Côte d'Ivoire vs Dominican Republic: Leprosy registered prevalence rate per 1 000 000 population
Côte d'Ivoire
17.16
in 2024
Dominican Republic
18.11
in 2024
Côte d'Ivoire rank
38th
Dominican Republic rank
37th
Leprosy registered prevalence rate per 1 000 000 population over time
- Côte d'Ivoire
- Dominican Republic
How they compare
Dominican Republic currently reports 18.11 against 17.16 in Côte d'Ivoire, a difference of 0.95.
That makes Dominican Republic's figure about 1.1 times Côte d'Ivoire's.
The two have swapped places 1 time across 13 shared years of data; in 2012 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 38th and Dominican Republic ranks 37th of 169 countries.
Across the 2 decades both report, Côte d'Ivoire averaged higher in 1 and Dominican Republic in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Dominican Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 31.95 | 27.36 | 4.59 | Côte d'Ivoire |
| 2020s | 15.53 | 22.94 | 7.4 | Dominican Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher leprosy registered prevalence rate per 1 000 000 population, Côte d'Ivoire or Dominican Republic?
- Dominican Republic, at 18.11 against 17.16 in Côte d'Ivoire as of 2024.
- What is the difference in leprosy registered prevalence rate per 1 000 000 population between Côte d'Ivoire and Dominican Republic?
- 0.95, with Dominican Republic ahead.
- How many years of comparable data are there for Côte d'Ivoire and Dominican Republic?
- 13 years are reported by both, from 2012 to 2024.
- How do Côte d'Ivoire and Dominican Republic rank globally for leprosy registered prevalence rate per 1 000 000 population?
- Côte d'Ivoire ranks 38th and Dominican Republic ranks 37th of 169 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Leprosy registered prevalence rate per 1 000 000 population. Statizoid refreshes it automatically from the source and publishes the full history for both places.